PIS1 Antibody

Shipped with Ice Packs
In Stock

Description

Clarification of Terminology

The term "PIS1" refers to phosphatidylinositol synthase in Saccharomyces cerevisiae (budding yeast), where it catalyzes the synthesis of phosphatidylinositol, a critical phospholipid in cellular membranes . No antibodies targeting this yeast-specific protein are described in the provided sources.

By contrast, multiple antibodies against Presenilin-1 (PSEN1) – a protein linked to Alzheimer's disease – are extensively documented in the search results[1-6,9]. This suggests a possible confusion between "PIS1" and "PSEN1."

Antibodies Targeting PSEN1 (Presenilin-1)

While no "PIS1 antibodies" exist in the provided literature, PSEN1 antibodies are well-characterized. Key examples include:

Antibody NameHost SpeciesApplicationsTarget RegionKey Validation Data
ZooMAb® ZMS1101 MouseWB, ELISA, ICCC-terminal halfKD = 1.6 x 10⁻⁷ (Affinity binding assay); detects PSEN1 in HeLa, A431, and brain lysates
Proteintech 16163 RabbitWB, IHC, IPFull-length proteinValidated in human kidney, HeLa, and rodent brain tissues
Thermo MA1-751 MouseIF, IHC, WBN-terminal fragment (aa 21–34)Detects 28 kDa PS1 fragment in transfected cells; stains amyloid plaques in human brain
Thermo MA1-752 MouseWB, IP, ICCC-terminal fragment (aa 313–334)Identifies 18 kDa CT fragment and full-length PS1 in SH-SY5Y cells

Functional Insights from PSEN1 Antibody Studies

  • Alzheimer’s Research: PSEN1 antibodies like A16 and Fab16 have been used to study Aβ plaque clearance and synapse loss in APP/PS1 transgenic mice. A16 increased microglial engulfment of synapses via complement activation, exacerbating cognitive deficits despite reducing Aβ42 levels .

  • Clinical Relevance: Antibodies targeting PSEN1’s N-terminal (e.g., MA1-751) show strong staining of amyloid plaques and dystrophic neurites in human brain sections .

Neuropathological Effects of PSEN1 Antibodies

ParameterA16 (Full effector antibody)Fab16 (Fab fragment)
Aβ42 reductionSignificant (p < 0.05) Significant (p < 0.05)
Synapse lossIncreased (p < 0.01) No effect
Microglial activationMarkedly increased (p < 0.001) No change
Cognitive declineInduced in APP/PS1 mice Absent

Critical Analysis of Search Results

  • No PIS1 Antibody Data: None of the provided sources reference antibodies against yeast PIS1 or mammalian homologs.

  • PSEN1 Antibody Robustness: Five independent sources validate PSEN1 antibodies across species (human, mouse, rat) and applications (WB, IHC, ELISA)[1-6].

  • Therapeutic Implications: PSEN1 antibodies demonstrate dual roles – reducing Aβ plaques while potentially exacerbating neuroinflammation .

Recommendations for Further Investigation

  1. Terminology Verification: Confirm whether "PIS1" refers to yeast phosphatidylinositol synthase or is a typographical error for "PSEN1."

  2. Antibody Cross-Reactivity: If studying mammalian systems, prioritize PSEN1 antibodies with validated reactivity (e.g., ZooMAb® ZMS1101 or Thermo MA1-752).

  3. Functional Assays: For Alzheimer’s models, consider antibodies like A16 for Aβ clearance studies but monitor neuroinflammatory side effects .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PIS1; PIS; YPR113W; P8283.5; CDP-diacylglycerol--inositol 3-phosphatidyltransferase; Phosphatidylinositol synthase; PI synthase; PtdIns synthase
Target Names
PIS1
Uniprot No.

Target Background

Gene References Into Functions
  1. Research has shown that inositol and CDP-diacylglycerol synthesized in the cytosol can access the active site of the yeast PI synthase Pis1 from the cytosolic side. Additionally, the structure of Pis1 is significantly affected by mild detergents. PMID: 25687304
  2. A comprehensive study employed a genomic screen, database mining, and traditional promoter analysis to identify genes that influence PIS1 expression. PMID: 15755922
  3. The PIS1-encoded phosphatidylinositol synthase in Saccharomyces cerevisiae is regulated by zinc. PMID: 15980062
  4. Enhanced phosphatidylinositol synthesis might explain the suppression of rsp5 defects by PIS1. PMID: 16363994
  5. Multiple upstream AUG codons are present in at least some PIS1 transcripts, negatively impacting PIS1 expression. PMID: 16997274

Show More

Hide All

Database Links

KEGG: sce:YPR113W

STRING: 4932.YPR113W

Protein Families
CDP-alcohol phosphatidyltransferase class-I family
Subcellular Location
Microsome membrane; Multi-pass membrane protein. Endoplasmic reticulum membrane; Multi-pass membrane protein. Mitochondrion outer membrane; Multi-pass membrane protein.

Q&A

What is PIS1 Antibody and what antimicrobial peptide does it target?

PIS1 antibody is an affinity-purified rabbit polyclonal antibody specifically raised against the whole mature peptide sequence of Atlantic cod Piscidin-1 (Pis1). Pis1 belongs to the piscidin family of antimicrobial peptides that are crucial for innate defense mechanisms in teleost fish. The antibody targets the specific 23-mer peptide fragment with the sequence C-FIHHIIGWISHGVRAIHR AIHG, which represents the mature Pis1 peptide .

Piscidins are small molecular weight proteins with broad-spectrum antimicrobial activity against various pathogenic microorganisms. These antimicrobial peptides constitute a critical component of the innate immune system in fish species. Atlantic cod, a basal fish from the superorder Paracanthopterygii, possesses multiple piscidin peptides, including two paralogues (pis1 and pis2) and a novel alternative splice variant of pis2 .

How is PIS1 Antibody produced and validated for research use?

The production of PIS1 antibody follows a rigorous process to ensure specificity and minimal cross-reactivity. Initially, the synthetic peptide representing the Pis1 sequence is conjugated to keyhole limpet hemocyanin (KLH) as a carrier protein. This conjugate is then injected into rabbits to induce antibody production. The antiserum obtained is subsequently affinity-purified by passing it through a column containing the 23-mer Pis1 fragment conjugated to cyanogen bromide-activated agarose as an immunosorbent .

Validation involves multiple steps:

  • ELISA confirmation with a resulting titer of 1:64,000

  • Cross-reactivity assessment showing less than 1% cross-reactivity

  • Western blot analysis demonstrating no reactivity with synthetic Pis2 or Pis2b peptides

  • Immunohistochemistry (IHC) controls including:

    • Pre-incubation with Pis1 peptide (negative control)

    • Pre-incubation with related peptides (Pis2) or non-related peptides (cecropin P1)

    • Dilution buffer alone controls

    • Anti-cod galectin antibody comparisons

What is the tissue distribution pattern of Pis1 as detected by PIS1 Antibody?

PIS1 antibody reveals a remarkably ubiquitous distribution of Pis1 peptide throughout multiple tissues and cell types in Atlantic cod, suggesting its multifunctional role beyond antimicrobial activity. The distribution pattern can be summarized as follows:

Tissue/Organ SystemCell Types Showing Pis1 Immunoreactivity
Immune SystemThrombocyte-like cells, phagocytes, hematopoietic cells, multi-granular cells
KidneyGlomerular cells, columnar epithelial cells of collecting tubules, cell debris in renal tubule lumen
SpleenHematopoietic cells near blood vessels
Nervous SystemParasympathetic ganglia, perikarya, photoreceptor cells, inner nuclear layer of retina
Glandular TissuesExocrine pancreatic acinar cells, secretory cells in corpuscles of Stannius
CartilageChondrocytes (first report of AMP in fish cartilage)
Swim BladderMucosal epithelial cells, neural cells, fibroblasts, secretory cells of gas gland

This extensive distribution underscores the multifaceted roles of Pis1 beyond conventional immune defense mechanisms .

What are the optimal protocols for using PIS1 Antibody in immunohistochemistry?

The optimal immunohistochemistry protocol for PIS1 antibody application involves several critical steps:

Tissue Preparation and Antigen Retrieval:

  • Dewax paraffin sections with xylene followed by rehydration through decreasing ethanol gradients

  • Perform antigen retrieval using Tris-EDTA buffer (10 mM Tris-Base, 1 mM EDTA, pH ~9) at high temperature (autoclave at 100°C for 10 minutes)

  • Cool sections at room temperature for 20 minutes

Immunostaining Procedure:

  • Wash sections three times with deionized water (5 minutes each)

  • Quench endogenous peroxidase with 3% hydrogen peroxide in 100% methanol (10 minutes)

  • Wash three times with washing buffer (1.5% Tween 20 in 0.1 M PBS) for 10 minutes each

  • Block with 5% BSA in 0.1 M PBS for 1 hour at room temperature

  • Incubate with primary anti-PIS1 antibody at 1:50 dilution (~14.5 μg·ml⁻¹) overnight at 4°C

  • Wash three times with washing buffer (10 minutes each)

  • Incubate with HRP-conjugated secondary anti-rabbit antibody at 1:800 dilution for 30 minutes

  • Wash three times with washing buffer

  • Develop with DAB solution (3-10 minutes)

  • Counterstain lightly with hematoxylin

  • Dehydrate and mount with Eukitt mounting medium

This protocol has been optimized through extensive testing of different antigen retrieval methods, antibody dilutions, and development conditions.

How can researchers confirm the specificity of PIS1 Antibody in their experiments?

Confirming the specificity of PIS1 antibody requires implementing multiple control strategies:

Essential Control Experiments:

  • Peptide Competition Assay: Pre-incubate the antibody with synthetic Pis1 peptide (ratio 1:2 for antibody:peptide concentration) at 37°C for 45 minutes before dilution and application to tissue sections. The absence of immunostaining confirms specificity for the Pis1 epitope .

  • Non-related Peptide Controls: Pre-incubate the antibody with either:

    • A related peptide (e.g., Pis2) to assess cross-reactivity within the same peptide family

    • An unrelated peptide (e.g., cecropin P1) to confirm general specificity
      Persistent immunostaining with these controls but absence with Pis1 peptide confirms specificity .

  • Western Blot Validation: Test antibody reactivity against:

    • Synthetic Pis1 peptide (positive control)

    • Synthetic Pis2 and Pis2b peptides (to rule out cross-reactivity)

    • Tissue extracts (to confirm detection of native protein)

  • Omission Controls: Replace primary antibody with dilution buffer alone .

  • Alternative Antibody Controls: Use an unrelated antibody (e.g., anti-cod galectin antibody) to identify false positive reactions in test tissues .

These comprehensive controls establish the reliability of immunostaining results and confirm that observed patterns truly represent Pis1 distribution.

What dilution ratios and buffer systems are optimal for PIS1 Antibody applications?

Optimizing dilution ratios and buffer systems is crucial for achieving high-quality results with minimal background when using PIS1 antibody:

Primary Antibody Dilution:

  • Optimal dilution: 1:50 (~14.5 μg·ml⁻¹)

  • Tested range: 1:25, 1:50, 1:100, 1:400, and 1:800

  • Dilution buffer: 1.5% bovine serum albumin (BSA) in 0.1 M PBS

Secondary Antibody Dilution:

  • Optimal dilution: 1:800 for HRP-conjugated anti-rabbit antibody

  • Tested range: 1:400, 1:800, 1:1200, and 1:2000

Buffer Systems:

  • Washing Buffer: 1.5% Tween 20 in 0.1 M PBS

  • Blocking Solution: 5% BSA in 0.1 M PBS

  • Antigen Retrieval Buffers:

    • Preferred: Tris-EDTA buffer (10 mM Tris-Base, 1 mM EDTA, pH ~9)

    • Alternative (less effective): Citrate buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0)

The optimal parameters were determined through systematic testing and provide the best balance between specific immunostaining and minimal background.

How can PIS1 Antibody be used to investigate immune cell functions in fish species?

PIS1 antibody serves as a powerful tool for investigating immune cell functions in fish, offering insights into both cellular distribution and functional roles of this antimicrobial peptide:

Phagocyte Identification and Functional Analysis:

  • Combine latex bead phagocytosis assays with PIS1 immunostaining to correlate phagocytic activity with Pis1 expression

  • Quantify Pis1 immunoreactivity in phagocytes with different levels of bead uptake to assess correlation between phagocytic capacity and Pis1 production

  • Compare Pis1 distribution in phagocytes from different organs (e.g., head kidney versus spleen)

Hematopoietic Tissue Analysis:

  • Map Pis1 expression across developmental stages of immune cell lineages

  • Correlate Pis1 expression with cell maturation markers

  • Identify specific hematopoietic cell populations that produce Pis1

Leukocyte Subset Characterization:

  • Perform dual immunostaining with PIS1 antibody and markers for specific leukocyte subpopulations

  • Isolate leukocyte subsets (thrombocyte-like cells, granulocytes) and analyze Pis1 expression patterns

  • Compare Pis1 distribution in stimulated versus unstimulated leukocytes

These approaches provide insights into how Pis1 contributes to both intracellular and extracellular killing mechanisms in the fish immune system.

What insights does PIS1 Antibody provide about antimicrobial peptide distribution in non-immune tissues?

PIS1 antibody has revealed unexpected distribution patterns of Pis1 peptide in non-immune tissues, suggesting broader physiological roles beyond direct antimicrobial activity:

Neuronal Tissues:

  • Strong Pis1 immunoreactivity in parasympathetic ganglia on the surface of head kidney

  • Presence in photoreceptor cells and inner nuclear layer of retina

  • Abundant expression in neural cells within swim bladder wall

Cartilaginous Tissues:

  • First report of an antimicrobial peptide in fish cartilage

  • Pis1-positive chondrocytes suggest potential roles in cartilage development or protection

Exocrine and Endocrine Glands:

  • Strong immunoreactivity in pancreatic acinar cells

  • Presence in secretory cells of corpuscles of Stannius (calcium-regulating endocrine glands)

Reproductive Tissues:

  • Detection in oocytes suggests potential roles in reproductive immunology

These distribution patterns indicate that Pis1 may function beyond conventional immune defense, potentially contributing to tissue homeostasis, development, or specialized physiological functions in various organ systems. The expression in neuronal tissues is particularly intriguing and suggests possible neuromodulatory roles or neuronal protection mechanisms.

How does PIS1 Antibody help distinguish between intracellular and extracellular antimicrobial mechanisms?

PIS1 antibody serves as a valuable tool for discriminating between intracellular and extracellular antimicrobial mechanisms, providing insights into the dual functionality of Pis1 peptide:

Intracellular Killing Mechanisms:

  • PIS1 immunostaining reveals strong presence in phagocytic cells, particularly those that have engulfed latex beads

  • Higher immunoreactivity in phagocytes with greater bead uptake suggests that Pis1 production is enhanced during active phagocytosis

  • The presence of Pis1 in phagocytic vacuoles and granules indicates its role in intracellular digestion of pathogens

Extracellular Killing Mechanisms:

  • Detection of Pis1 peptide in extracellular spaces, particularly in immune organs and mucosal surfaces

  • Presence in secretory cells and various epithelial surfaces suggests active secretion

  • Detection in luminal contents of renal tubules indicates secretion and potential antimicrobial activity in body fluids

MechanismKey Evidence from PIS1 Immunostaining
IntracellularStrong signal in phagocytes with engulfed beads; Presence in cellular granules; Correlation between phagocytic activity and signal intensity
ExtracellularDetection in extracellular matrix; Presence in secretory cells; Detection in body fluid compartments

This dual functionality highlights the versatility of Pis1 as an antimicrobial agent that can target pathogens both within phagocytic cells and in extracellular environments .

What antigen retrieval methods are most effective when using PIS1 Antibody in different tissue types?

Optimizing antigen retrieval is critical for successful immunohistochemistry with PIS1 antibody. Based on systematic testing, the following approaches are recommended:

Preferred Antigen Retrieval Method:

  • Buffer: Tris-EDTA buffer (10 mM Tris-Base, 1 mM EDTA, pH ~9)

  • Temperature: High temperature (autoclave at 100°C for 10 minutes)

  • Results: Strong Pis1 immunoreactivity with minimal background staining

Alternative Method (Less Effective):

  • Buffer: Citrate buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0)

  • Temperature: Either high temperature (autoclave at 100°C for 10 minutes) or low temperature (water bath at 65°C for 1 hour)

  • Results: Faint immunostaining compared to Tris-EDTA method

Tissue-Specific Considerations:

  • Cartilaginous Tissues: May require extended antigen retrieval time due to dense matrix

  • Highly Cellular Tissues (e.g., hematopoietic tissues): Standard protocol is usually sufficient

  • Epithelial Tissues: Standard protocol with careful monitoring to prevent over-retrieval and tissue damage

The high-temperature Tris-EDTA method was identified as superior through comparative testing and should be the first-choice approach for most tissue types when using PIS1 antibody.

How should researchers interpret PIS1 Antibody results in comparative studies across different fish species?

When using PIS1 antibody for comparative studies across fish species, researchers should consider several important factors to ensure accurate interpretation:

Sequence Homology Considerations:

  • The specificity of anti-Pis1 antibody is based on recognition of the Atlantic cod Pis1 peptide sequence

  • Piscidin sequences vary across fish species, with different degrees of conservation

  • Structural diversification and low identity (36% or 41%) between Pis1 and Pis2/Pis2b contribute to antibody specificity

Recommended Validation Approaches:

  • Sequence Alignment Analysis: Compare Pis1 sequences between target species and Atlantic cod to predict potential cross-reactivity

  • Western Blot Validation: Test antibody reactivity against synthetic peptides representing piscidin variants from each species

  • Absorption Controls: Pre-incubate antibody with species-specific piscidin peptides to assess cross-reactivity

Interpretation Guidelines:

  • Strong signals in species with high sequence homology to Atlantic cod Pis1 likely represent true piscidin distribution

  • Weak signals in species with low sequence homology require additional validation

  • In species with multiple piscidin variants, the antibody may recognize some but not all variants

  • Negative results should be interpreted cautiously as they may reflect sequence divergence rather than absence of piscidin peptides

These considerations help ensure that comparative studies accurately reflect genuine biological differences rather than technical limitations of the antibody.

What techniques can be combined with PIS1 Antibody immunostaining for advanced functional studies?

Integrating PIS1 antibody immunostaining with complementary techniques enables more comprehensive functional studies of Pis1 peptide:

1. Combined Phagocytosis and Immunostaining Assays:

  • Pre-incubate leukocytes with fluorescent latex beads or labeled bacteria

  • Perform PIS1 immunostaining to correlate phagocytic activity with Pis1 expression

  • Quantify both phagocytic index and Pis1 immunoreactivity

2. Dual Immunofluorescence Labeling:

  • Combine PIS1 antibody with markers for specific cell types or subcellular compartments

  • Use differently labeled secondary antibodies for simultaneous visualization

  • Perform confocal microscopy to assess co-localization patterns

3. In Situ Hybridization with Immunohistochemistry:

  • Detect pis1 mRNA expression using in situ hybridization

  • Follow with PIS1 immunostaining on the same sections

  • Compare transcriptional and translational patterns to identify potential post-transcriptional regulation

4. Immunoelectron Microscopy:

  • Apply PIS1 antibody with gold-conjugated secondary antibodies

  • Visualize ultrastructural localization of Pis1 peptide

  • Determine precise subcellular compartmentalization

5. Functional Assays with Immunodepletion:

These integrated approaches provide deeper insights into both the distribution and functional significance of Pis1 in diverse biological contexts.

How can PIS1 Antibody contribute to understanding evolutionary aspects of antimicrobial peptides?

PIS1 antibody offers valuable tools for investigating evolutionary aspects of antimicrobial peptides across fish species and beyond:

Comparative Immunohistochemistry Studies:

  • Use PIS1 antibody in phylogenetically diverse fish species to map conservation patterns

  • Compare tissue distribution patterns between basal fish (like Atlantic cod) and more derived teleosts

  • Identify conserved versus divergent expression patterns that may reflect evolutionary adaptations

Structure-Function Relationships:

  • Correlate immunostaining patterns with known structural variations in piscidin peptides

  • Investigate how sequence divergence relates to tissue-specific expression patterns

  • Combine with functional assays to relate structural features to antimicrobial potency

Evolutionary Innovations:

  • The discovery of Pis1 in chondrocytes represents the first report of antimicrobial peptides in fish cartilage

  • Further investigation of this unexpected localization may reveal novel evolutionary adaptations

  • Comparative studies across species could identify when this feature emerged in vertebrate evolution

These approaches can help reconstruct the evolutionary history of piscidin peptides and identify key adaptations that have shaped their distribution and function across vertebrate lineages.

What advantages does PIS1 Antibody offer for studying innate immunity in diverse aquatic species?

PIS1 antibody provides several distinct advantages for investigating innate immunity across aquatic species:

Comprehensive Tissue Mapping:

  • The antibody enables systematic mapping of Pis1 distribution across diverse tissue types

  • This comprehensive approach has revealed unexpected localizations, such as in neuronal tissues and cartilage

  • Such mapping facilitates understanding of the multifunctional nature of antimicrobial peptides beyond direct pathogen killing

Cellular-Level Resolution:

  • Immunohistochemistry with PIS1 antibody provides cellular and subcellular resolution

  • This precision allows identification of specific cell types involved in Pis1 production

  • The technique reveals how Pis1 distribution relates to functional specialization of different cell types

Integration with Functional Studies:

  • PIS1 antibody can be used in combination with functional assays (e.g., phagocytosis)

  • This integration connects structural localization with functional activity

  • Such approaches help distinguish between intracellular and extracellular antimicrobial mechanisms

Applications in Aquaculture:

  • Understanding Pis1 distribution patterns can inform health monitoring in commercially important fish species

  • Comparative studies can identify species-specific variations that may correlate with disease resistance

  • Knowledge of antimicrobial peptide biology contributes to development of non-antibiotic disease management strategies

These advantages position PIS1 antibody as a valuable tool for comprehensive investigation of innate immunity in diverse aquatic species with both basic research and applied implications.

What emerging research areas could benefit from PIS1 Antibody applications?

The versatility of PIS1 antibody opens doors to several emerging research areas beyond traditional immunology:

Neuroimmunology Interactions:
The unexpected discovery of Pis1 peptide in neuronal tissues suggests potential neuroimmune interactions. Future research could explore:

  • The role of Pis1 in neural protection against infections

  • Potential signaling functions of Pis1 between immune and nervous systems

  • Evolutionary conservation of neuronal antimicrobial peptide expression across vertebrates

Developmental Biology:
The presence of Pis1 in diverse tissue types raises questions about its role in development:

  • Temporal expression patterns during embryonic and post-embryonic development

  • Potential roles in tissue modeling and remodeling

  • Contributions to establishing sterile environments during organogenesis

Comparative Immunology:
PIS1 antibody enables detailed comparative studies:

  • Distribution patterns across phylogenetically diverse fish species

  • Correlation between piscidin distribution and environmental adaptation

  • Relation between piscidin expression and disease resistance

Environmental Immunology:
PIS1 antibody could help investigate how environmental factors affect antimicrobial peptide expression:

  • Effects of temperature, salinity, or pollutants on Pis1 distribution

  • Seasonal variations in piscidin expression

  • Immunomodulatory effects of environmental stressors on antimicrobial peptide production

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.